Partnership Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$614K Hold
2,349
– – 0.44% 35
2026
Q2
$591K Hold
2,349
– – 0.4% 38
2026
Q1
$511K Hold
2,349
– – 0.39% 43
2025
Q4
$537K Hold
2,349
– – 0.39% 43
2025
Q3
$544K Hold
2,349
– – 0.42% 43
2025
Q2
$436K Hold
2,349
– – 0.35% 49
2025
Q1
$492K Hold
2,349
– – 0.42% 48
2024
Q4
$417K Hold
2,349
– – 0.35% 51
2024
Q3
$464K Hold
2,349
– – 0.33% 50
2024
Q2
$403K Hold
2,349
– – 0.3% 61
2024
Q1
$428K Hold
2,349
– – 0.3% 73
2023
Q4
$386K Buy
+2,349
New +$342K 0.29% 73

Other funds holding ABBV

Partnership Wealth Management's ABBV Position: Q3 2026 in Review

Partnership Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 2,349 shares worth $614K. The position accounts for 0.44% of the portfolio, ranked #35.

Partnership Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Partnership Wealth Management held 2,349 shares of AbbVie worth $614K as of Q3 2026.
  • Partnership Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.44% of Partnership Wealth Management's portfolio in Q3 2026, its #35 holding.
  • Partnership Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.